Isla, Leopoldo Perez de; Ray, Kausik K.; Watts, Gerald F.; Santos Filho, Raul Dias dos 
; Alonso, Rodrigo; Muniz-grijalvo, Ovidio; Diaz-diaz, Jose Luis; Badimon, Lina; Catapano, Alberico L; Mata, Pedro
Source: Atherosclerosis. Unidade: FM
Subjects: HIPERCOLESTEROLEMIA, AVALIAÇÃO DE RISCO, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ISLA, Leopoldo Perez de et al. Potential utility of the SAFEHEART risk equation for rationalising the use of PCSK9 monoclonal antibodies in adults with heterozygous familial hypercholesterolemia. Atherosclerosis, v. 286, p. 40-45, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2019.05.003. Acesso em: 06 nov. 2024.APA
Isla, L. P. de, Ray, K. K., Watts, G. F., Santos Filho, R. D. dos, Alonso, R., Muniz-grijalvo, O., et al. (2019). Potential utility of the SAFEHEART risk equation for rationalising the use of PCSK9 monoclonal antibodies in adults with heterozygous familial hypercholesterolemia. Atherosclerosis, 286, 40-45. doi:10.1016/j.atherosclerosis.2019.05.003NLM
Isla LP de, Ray KK, Watts GF, Santos Filho RD dos, Alonso R, Muniz-grijalvo O, Diaz-diaz JL, Badimon L, Catapano AL, Mata P. Potential utility of the SAFEHEART risk equation for rationalising the use of PCSK9 monoclonal antibodies in adults with heterozygous familial hypercholesterolemia [Internet]. Atherosclerosis. 2019 ; 286 40-45.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2019.05.003Vancouver
Isla LP de, Ray KK, Watts GF, Santos Filho RD dos, Alonso R, Muniz-grijalvo O, Diaz-diaz JL, Badimon L, Catapano AL, Mata P. Potential utility of the SAFEHEART risk equation for rationalising the use of PCSK9 monoclonal antibodies in adults with heterozygous familial hypercholesterolemia [Internet]. Atherosclerosis. 2019 ; 286 40-45.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2019.05.003
